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Abstract : We investigated the safety and utility of endoscopic removal of common 
bile duct stones （CBDS） in the elderly.  In all, 253 patients with CBDS who 
underwent endoscopic retrograde cholangiopancreatography （ERCP） between Janu-
ary 2007 and December 2011 at Showa University Hospital were evaluated retro-
spectively.  The median age of the patients was 75 years ; thus, we divided patients 
into two groups, those aged ≥ 75 years （Group A ; n ＝ 134） and those aged ＜
75 years （Group B ; n＝ 119）.  Patients in Group A had signicantly higher rates 
of endoscopic sphincterotomy in palliative ERCP （24.8% vs. 10.7% ; p＝ 0.008） and 
palliative removal of CBDS （34.8% vs. 20.9% ; p ＝ 0.015） than patients in Group 
B.  However, the median dose of unitrazepam was signicantly lower for patients 
in Group A than Group B （1 vs. 1.4 mg, respectively ; p＜ 0.001）.  The rate of use 
of pentazocine （18.5% vs. 54.7% ; p＜ 0.001） and scopolamine butylbromide （6.2% 
vs. 23.9% ; p＜ 0.01） was signicantly lower in Group A patients, whereas the use 
of glucagon was significantly higher in this group （43.8 vs. 15.4% ; p ＜ 0.001）.  
There were no signicant differences in the rate of successful endoscopic removal 
of CBDS, treatment time, complications, and the recurrence of CBDS between the 
two groups.  Endoscopic removal of CBDS in the elderly is a safe procedure with 
good outcomes if the appropriate treatment is selected.
Key words : common bile duct stones （CBDS）, elderly, endoscopic removal, endoscopic 
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Introduction
　Advances in medical care, nutrition, and hygiene have resulted in an increased lifespan of the 
Japanese population.  This aging of society will likely increase the incidence of age-related diseas-
es.  Thus, the need for endoscopic removal of common bile duct stones （CBDS） in the elderly 
is likely to increase, because CBDS are more common with aging 1）.  Previous reports suggest 
that the elderly can safely undergo endoscopic procedures 2-5）.  However, the risk of complications 
during endoscopic procedures is higher in the elderly than in young patients because of reduced 
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cardiopulmonary and immune function.
　The aim of the present study was to evaluate the safety and utility of endoscopic removal of 
CBDS in elderly patients at Showa University Hospital.
Methodology
Patients
　Two hundred and fty-three patients assessed as having CBDS by abdominal ultrasonography, 
computed tomography, magnetic resonance cholangiopancreatography, or endoscopic ultrasonogra-
phy were evaluated retrospectively.  All patients had a naïve papilla of Vater and had undergone 
endoscopic retrograde cholangiopancreatography （ERCP） between January 2007 and December 
2011 at Showa University Hospital.  Information was obtained for all patients regarding their 
age, gender, diameter of the common bile duct, the number and diameter of CBDS, and the 
prevalence of gallstones.  In addition, we determined, the rate of cholangitis or cholecystitis, the 
use of oral antithrombotic agents, the rate of endoscopic sphincterotomy （EST） or endoscopic 
papillary balloon dilation （EPBD）, whether the removal of CBDS was successful, the time 
required for endoscopic removal of CBDS and the endoscopic procedure overall, complications 
after ERCP, and the rate of recurrence of CBDS.
Procedures
　Written informed consent was obtained from all patients for the endoscopic removal of CBDS. 
This study was approved by the Ethics Review Board of Showa University Hospital.
　ERCP was performed with patients in the prone position.  Patients were sedated with ben-
zodiazepines ; pentazocine was used as an analgesic and scopolamine butylbromide or glucagon 
were used as antispasmodic agents.  If patients were receiving antithrombotic agents, the proce-
dure was performed after discontinuation of the drug.
　In most cases, ERCP was performed using a duodenoscope （JF260V ; Olympus Medical 
Systems, Tokyo, Japan）, whereas a gastroscope or colonoscope was used in patients with recon-
structed gastrointestinal anatomy （Billroth II or Roux-en-Y）.  The sphincterotomes used for EST 
were the Autotome RX （Boston Scientic, Natick, MA, USA） and the CleverCut 3V （Olympus 
Medical Systems）; the biliary balloon dilator for EPBD was the Max Force TTS （Boston Sci-
entic）; and the guidewire system used was the Jagwire Plus （Boston Scientic） or VisiGlide 
（Olympus Medical Systems）.
　In most cases, EST with a small or medium-sized incision of the papilla of Vater was per-
formed for endoscopic removal of CBDS.  When EST could not be performed, such as in 
patients with coagulopathies, those taking antithrombotic medication or those with reconstructed 
gastrointestinal anatomy （Billroth-II or Roux-en-Y）, EPBD was performed.  In cases of large 
stones, EPBD with EST was performed.  Balloon and basket catheters or mechanical lithotripsy 
were used for the endoscopic removal of CBDS.
　Patients with acute moderate or severe cholangitis, as determined according to the Flowcharts 
for the diagnosis and treatment of acute cholangitis and cholecystitis : Tokyo Guidelines 6）, under-
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went emergency ERCP with antibiotic and uid therapy.  Palliative ERCP was performed in all 
other patients.
Statistical analysis
　Data are given as median values with the range given in parentheses.  Statistical analyses were 
performed using StatMate III version 3.16 （ATMS, Tokyo, Japan）.  Data were analyzed by the 
Mann-Whitney U-test and Chi-squared test, with two-tailed p＜ 0.05 considered signicant.
Results
　Two hundred and fty-three patients with choledocholithiasis of a naïve papilla of Vater who 
underwent ERCP were evaluated retrospectively.  As indicated in Table 1, the median age 
Table 1.  Baseline clinical characteristics and therapeutic results for 
253 patients with common bile duct stones who underwent 
endoscopic retrograde cholangiopancreatography
Age （years）   75 （17-97）
No. men/women 141/112
Diameter of the common bile duct （mm）  11 （4-25）
CBDS diameter
　< 10 mm 65.2% （165/253）
　≥ 10 mm 34.8% （88/253）
No. single/multiple CBDS 139/114
Presence of gallstones 67.6% （171/253）
Cholangitis or cholecystitis 56.2% （132/253）
Use of oral antithrombotic agents  8.3% （21/253）
EST 83.8% （212/253）
EPBD  5.1% （13/253）
EPBD with EST  9.9% （25/253）
Successful endoscopic removal of CBDS 97.6% （247/253）
Type of endoscopic removal of CBDS
　Emergency 71.7% （177/247）
　Palliative 28.3% （70/247）
Duration of ERCP （min）  30 （7-90）
Post-ERCP complications
　Pancreatitis  2.4% （6/253）
　Bleeding  2.8% （7/253）
　Perforation  0.8% （2/253）
Recurrence of CBDS  5.6% （14/248）
Unless indicated otherwise, data are given as the median （range） or 
as a percentage with the number of patients given in parentheses, as 
appropriate.
CBDS, common bile duct stones; EST, endoscopic sphincterotomy 
（EST）; EPBD, endoscopic papillary balloon dilation ; ERCP, 
endoscopic retrograde cholangiopancreatography.
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of patients was 75 years （range 17 ～ 97 years）; 141 were male and 112 were female.  The 
median diameter of the common bile duct at the point of cholangiography was 11 mm （range 
4 ～ 25 mm）.  The diameter of common bile duct was ＜ 10 mm in 165 patients （65.2%） and
＞ 10 mm in 88 patients （34.8%）.  One hundred and thirty-nine patients had a single CBDS, 
whereas 114 patients had multiple CBDS.  Gallstones were present in 171 patients （67.6%）, and 
132 patients （56.2%） had cholangitis and cholecystitis.  Twenty-one patients （8.3%） were taking 
antithrombotic medication.  The rate of EST, EPBD, and EPBD + EST was 83.8% （212/253）, 
5.1% （13/253）, and 9.9% （25/253）, respectively.  Endoscopic removal of CBDS was success-
ful in 247 patients （97.6%）.  The rate of emergency endoscopic removal of CBDS was 71.7% 
（177/247）.  The median endoscopic treatment time was 30 min （range 7 ～ 90 min）.  The rate 
of post-ERCP pancreatitis, bleeding, and perforation was 2.4% （6/253）, 2.8% （7/253）, and 0.8% 
（2/253）, respectively.  The recurrence rate of CBDS was 5.6% （14/248 ; Table 1）.
　Because the median age of the patients was 75 years, we divided the patients into two groups, 
namely those ≥ 75 years （Group A ; n＝ 134） and those＜ 75 years （Group B ; n＝ 119）.
　As indicated in Table 2, there were 63 men and 71 women in Group A, compared with 78 
men and 41 women in Group B.  Thus, there were signicantly more women in Group A than 
in Group B （p＝ 0.003）.
　Furthermore, the median diameter of the common bile duct was signicantly greater in Group 
A than in Group B patients （p＜ 0.001）.  Signicantly more patients in Group A had CBDS of
≥ 10 mm in diameter compared to Group B （p＜ 0.001）.
　In Group A, 68 and 66 patients had single and multiple CBDS, respectively, compared with 71 
and 48 patients, respectively, in Group B.  There were no signicant differences in the number of 
CBDS between the two groups.
　Gallstones were present in signicantly fewer patients in Group A than in Group B （p ＝
0.004）.  However, there was no signicant difference in the rate of cholangitis or cholecystitis 
between the two groups.
　Signicantly more patients were on oral antithrombotic agents in Group A than in Group B 
（p＝ 0.026）.  There were no signicant differences in the rate of EST, EPBD, and EPBD + EST 
between the two groups.  However, the rate of palliative EST was signicantly higher in Group 
A than in Group B （p＝ 0.008）.
　Endoscopic removal of CBDS was successful in 98.5% （132/134） of patients in Group A and 
in 96.6% （115/119） of patients in Group B.  The rate of palliative endoscopic removal of CBDS 
was signicantly higher in Group A than Group B patients （p＝ 0.015）.  The median endoscopic 
procedural time did not differ signicantly between the two groups.  
　The common complications after ERCP were acute pancreatitis, bleeding, and perforation. 
There were no signicant differences in the rate of post-ECRP complications between the two 
groups, with acute pancreatitis, bleeding, and perforation （Table 2）.  The rate of recurrence of 
CBDS in Groups A and B did not differ signicantly （Table 2）.
　As indicated in Table 3, flunitrazepam was used as a sedative during ERCP in 96.9% 
（126/130） of patients in Group A and in 96.6% （113/117） of patients in Group B.  The median 
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dose of unitrazepam used was signicantly lower in Group A than in Group B （p＜ 0.001）. 
The rate of use of pentazocine as an analgesic was significantly lower in Group A than in 
Group B （p＜ 0.001 ; Table 3）.  Similarly, the rate of use of scopolamine butylbromide as an 
antispasmodic agent was signicantly lower in Group A than in Group B （p＜ 0.001 ; Table 3）. 
However, the rate of use of glucagon was signicantly higher in Group A than in Group B （p＜
0.001 ; Table 3）.
Discussion
　Elderly patients are known to have diminished cardiopulmonary and immune function, and 
a higher incidence of underlying diseases, such as cerebrovascular disease 2）.  In addition, it is 
thought that the elderly are susceptible to biliary infection because they are prone to cholestasis 
Table 2.  Comparison of baseline characteristics and therapeutic results for patients in Group A （≥ 75 years） and 
Group B （< 75 years）
Group A （n = 134） Group B （n = 119） p-value
Age （years）   82 （75-97）   65 （17-74） < 0.001
No. men/women 63/71 78/41 0.003
Diameter of the common bile duct （mm）  12 （5-25）   9 （4-20） < 0.001
CBDS diameter
　< 10 mm  50.7 （68/134）  81.5 （97/119） < 0.001
　≥ 10 mm  49.3 （66/134）  18.5 （22/119） < 0.001
No. single/multiple CBDS 68/66 71/48 NS
Presence of gallstones 59.7% （80/134） 76.5% （91/119） 0.004
Cholangitis or cholecystitis 56.7% （76/134） 47.1% （56/119） NS
Use of oral antithrombotic agents 11.9% （16/134） 4.2% （5/119） 0.026
EST （%） 81.3% （109/134） 86.6% （103/119） NS
　Emergency EST 75.2% （82/109） 89.3% （92/103）
　Palliative EST 24.8% （27/109） 10.7% （11/103） 0.008
EPBD 6.0% （8/134） 4.2% （5/119） 0.008
EPBD with EST 11.9% （16/134） 7.6% （9/119） NS
Successful endoscopic removal of CBDS 98.5% （132/134） 96.6% （115/119） NS
Emergency or palliative endoscopic removal of CBDS NS
　Emergency 65.2% （86/132） 79.1% （91/115）
　Palliative 34.8% （46/132） 20.9% （24/115） 0.015
Duration of ERCP （min）  35 （7-90）  30 （8-85） 0.015
Post-ERCP complications NS
　Pancreatitis 2.2% （3/134） 2.5% （3/119）
　Bleeding 2.2% （3/134） 3.4% （4/119） NS
　Perforation 0.7% （1/134） 0.8% （1/119） NS
Recurrence of CBDS 6.8% （9/132） 4.3% （5/116） NS
Unless indicated otherwise, data are given as the median （range） or as a percentage with the number of patients 
given in parentheses, as appropriate.
CBDS, common bile duct stones ; EST, endoscopic sphincterotomy （EST）; EPBD, endoscopic papillary balloon 
dilation; ERCP, endoscopic retrograde cholangiopancreatography.
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（due to decreased bile secretion and gallbladder contractility） and retrograde infection due to 
dysfunction of the sphincter of Oddi.  Hence, the incidence of CBDS also increases with aging 1）.
　Several studies have reported the usefulness and safety of endoscopic removal of CBDS in 
elderly patients 2-5）.  In the present study, the time for the endoscopic removal of CBDS, post-
ERCP complications （pancreatitis, bleeding and perforation）, and the success and recurrence rates 
for endoscopic removal of CBDS did not differ signicantly between patients aged ≥ 75 years 
（Group A） and those＜ 75 years of age （Group B）.  These ndings may suggest the usefulness 
and safety of endoscopic removal of CBDS in the elderly.  In addition, there are several reports 
of successful EST and EPBD of the papilla of Vater for endoscopic removal of CBDS in elderly 
patients 3，7，8）.  Because EST is the method of choice for the endoscopic removal of CBDS at 
Showa University Hospital, the rate of EPBD was less than that of EST in both Groups A and 
B, with no signicant differences between them.  Further, the low complication rate following 
both EST and EPBD in the present study suggests that both procedures can be safely and suc-
cessfully performed in elderly patients.
　Whether endoscopic removal of CBDS should be performed as an emergency or pallia-
tive procedure in patients with acute cholangitis is a subject of considerable discussion.  The 
revised Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis : Tokyo 
Guidelines 6） recommend emergency or early drainage for CBDS with moderate or severe acute 
cholangitis.  In the present study, palliative removal of CBDS was more common in Group A 
than in Group B.  
　Furthermore, the number of palliative EST procedures performed in Group A was signifi-
cantly higher than in Group B.  This result could be due to the fact that many of the elderly 
patients were receiving antithrombotic agents for the treatment of concomitant cardiovascular 
Table 3.  Comparison of the use of sedative, analgesic, and antispasmodic agents for patients 
in Group A （≥ 75 years） and Group B （< 75 years）.
Group A （n = 134） Group B （n = 119） p-value
Flunitrazepam
　Rate of use 96.9% （126/130） 96.6% （113/117） NS
　Dose （mg） 1 （0.2-2） 1.4 （0.4-2.8） < 0.001
Pentazocine
　Rate of use 18.5% （24/130） 54.7% （64/117） < 0.001
　Dose （mg） 15 （7.5-22.5） 15 （7.5-22.5） NS
Scopolamine butylbromide
　Rate of use 6.2% （8/130） 23.9% （28/117） < 0.001
　Dose （mg） 10 （5-20） 20 （5-40） NS
Glucagon
　Rate of use 43.8% （57/130） 15.4% （18/117） < 0.001
　Dose （mg） 0.5 （0.25-2） 0.5 （0.25-2） NS
Data are given as the median （range） or as a percentage with the number of patients given 
in parentheses, as appropriate.
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or cerebrovascular disease.  In the present study, endoscopic removal of CBDS was difcult in 
some cases.  Although patients for whom endoscopic removal of CBDS is likely to be difcult 
should preferably undergo open surgery ; choledochotomy in elderly patients is reportedly associ-
ated with signicant mortality, a positive rate of blood culture, and a prolonged hospital stay 
compared with young patients 9）.  Hence, long-term biliary stent placement is used to treat some 
elderly patients in whom endoscopic removal of CBDS is difcult 3）; this procedure is reportedly 
useful in patients at a later stage and with a short life expectancy 10-11）.  However, De Palma et 
al. found that stent placement was not problem free in 40%～ 41% of patients followed up for 
a period of 117 days after biliary stenting 12）.  Hence, if a biliary stent is placed following difcult 
endoscopic removal of CBDS, the stent should be replaced regularly.
　In the present study, the diameter of the bile duct in Group A was larger than that in Group 
B.  The bile duct is known to expand with age 13）.  Furthermore, inammation of the duodenal 
papilla and hypofunction of the sphincter of Oddi are more common with aging.  The greater 
incidence of larger CBDS in Group A patients is likely to be secondary to retrograde infection 
resulting from dysfunction of the sphincter of Oddi and prolonged cholestasis.
　There is a tendency for a greater prevalence of gallstones with aging.  However, in the pres-
ent study there were fewer patients with gallstones in Group A than in Group B.  This could 
be due to greater food intake in young people compared with the elderly, resulting in a greater 
tendency for gallstone formation in young people.
　Scopolamine butylbromide was more often used as an antispasmodic agent in Group B, where-
as glucagon was more often used in Group A.  This could reect the fact that scopolamine 
butylbromide is less frequently used in elderly patients with underlying diseases such as hyper-
tension, cardiopathy, glaucoma, and prostatic hypertrophy.  The use of unitrazepam in Group A 
was less than that in Group B, and this could reect the fact that the effects of sedatives are 
exaggerated in the elderly due to impaired hepatic and renal function.
　It has been reported that low-dose propofol provides stable sedation for ERCP in patients
≥ 90 years of age 14）.  A previous study performed in patients aged between 23 and 94 years 
reported an incidence of cardiopulmonary complications following ERCP of 4.1% in those aged
＜ 80 years, compared with 7.1% in those aged ≥ 80 years 15）.  Hence, propofol may be a suitable 
agent for effective sedation in patients aged ≥ 80 years.  These observations suggest that the use 
of sedatives in the elderly is safe provided that these agents are used with care.
　In conclusion, the time required for the endoscopic removal of CBDS, post-ERCP complica-
tions （pancreatitis, bleeding and perforation）, the success of the procedure, and the recurrence 
of CBDS after removal did not differ signicantly between the elderly （Group A） and young 
（Group B） patients in the present study.  These ndings suggest that, using appropriate sedative, 
analgesic, and antispasmodic agents, manipulation of the papilla of Vater, and proper timing of 
endoscopic removal of bile duct stones, ERCP can be performed safely in elderly patients to 
remove CBDS.
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